Literature DB >> 24685914

Investigation of using diffusion-weighted magnetic resonance imaging to evaluate the therapeutic effect of esophageal carcinoma treatment.

Lan Wang1, Chun Han, Shuchai Zhu, Gaofeng Shi, Qi Wang, Hua Tian, Jie Kong, Andu Zhang.   

Abstract

AIM: To explore the associations of diffusion-weighted magnetic resonance imaging (DWI) measurements with the therapeutic effect (TE) on and survival of esophageal carcinoma patients treated with chemoradiotherapy (CRT).
METHODS: From March 2010 to December 2011, 77 patients were prospectively enrolled into a cohort study. DWI was performed at the beginning and 1-3 months after CRT. The immediate post-CRT TE was evaluated according to the Response Evaluation Criteria in Solid Tumors (RECIST). The associations between the disappearance status of hyperintense expression (HE) in DWI and the apparent diffusion coefficient (ADC) of DWI with the complete response (CR) as TE and survival were analyzed.
RESULTS: 3 patients were excluded due to the absence of HE in DWI. Analysis of the remaining 74 patients indicated that their ADC values were significantly improved from 1.64 ± 0.48 to 2.65 ± 0.58 mm2/s from pre-CRT to post-CRT (p = 0.000). Both univariate and multivariate Cox model analyses showed that high post-CRT ADC values and the disappearance status of HE associated significantly with the TE (CR rate) and survival.
CONCLUSIONS: DWI examination could afford useful markers to predict the treatment response as well as the survival of patients with esophageal squamous cell carcinoma. The non-disappearance of HE in DWI and low ADC values after CRT were risk factors.

Entities:  

Mesh:

Year:  2014        PMID: 24685914     DOI: 10.1159/000360210

Source DB:  PubMed          Journal:  Oncol Res Treat        ISSN: 2296-5270            Impact factor:   2.825


  7 in total

1.  Prognostic utility of diffusion-weighted MRI in oesophageal cancer: is apparent diffusion coefficient a potential marker of tumour aggressiveness?

Authors:  Francesco Giganti; Annalaura Salerno; Alessandro Ambrosi; Damiano Chiari; Elena Orsenigo; Antonio Esposito; Luca Albarello; Elena Mazza; Carlo Staudacher; Alessandro Del Maschio; Francesco De Cobelli
Journal:  Radiol Med       Date:  2015-09-21       Impact factor: 3.469

2.  Examination of the predictive factors of the response to whole brain radiotherapy for brain metastases from lung cancer using MRI.

Authors:  Shuri Aoki; Tomonori Kanda; Noriyuki Matsutani; Nobuhiko Seki; Masafumi Kawamura; Shigeru Furui; Hideomi Yamashita
Journal:  Oncol Lett       Date:  2017-05-26       Impact factor: 2.967

3.  Predictive Value of Early Response to Chemoradiotherapy in Advanced Esophageal Squamous Cell Carcinoma by Diffusion-Weighted MR Imaging.

Authors:  Wei Chen; Ya-Ting Wang; Lili Guo; Zhaohuan Zhu; Hai-Fei Zhou; Genji Bai
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

4.  Combination of DCE-MRI and DWI in Predicting the Treatment Effect of Concurrent Chemoradiotherapy in Esophageal Carcinoma.

Authors:  Changmin Liu; Roger Sun; Jing Wang; Fangling Ning; Zhenbo Wang; Judong Luo; Shaoshui Chen; Shuanghu Yuan
Journal:  Biomed Res Int       Date:  2020-06-16       Impact factor: 3.411

5.  Prognostic Value of Texture Analysis Based on Pretreatment DWI-Weighted MRI for Esophageal Squamous Cell Carcinoma Patients Treated With Concurrent Chemo-Radiotherapy.

Authors:  Zhenjiang Li; Chun Han; Lan Wang; Jian Zhu; Yong Yin; Baosheng Li
Journal:  Front Oncol       Date:  2019-10-17       Impact factor: 6.244

6.  Inter- and intra-observer reproducibility of ADC measurements in esophageal carcinoma primary tumors.

Authors:  Zhimin Ye; Jun Fang; Shujun Dai; Tieming Xie; Fangzheng Wang; Zhun Wang; Kai Li; Zhenfu Fu; Yuezhen Wang
Journal:  Oncotarget       Date:  2017-10-06

7.  Optimal timing for prediction of pathologic complete response to neoadjuvant chemoradiotherapy with diffusion-weighted MRI in patients with esophageal cancer.

Authors:  Alicia S Borggreve; Sophie E Heethuis; Mick R Boekhoff; Lucas Goense; Peter S N van Rossum; Lodewijk A A Brosens; Astrid L H M W van Lier; Richard van Hillegersberg; Jan J W Lagendijk; Stella Mook; Jelle P Ruurda; Gert J Meijer
Journal:  Eur Radiol       Date:  2019-12-10       Impact factor: 5.315

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.